Projects per year
Fingerprint
Dive into the research topics where Rafael Fonseca is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
-
Mayo Clinic Multiple Myeloma SPORE
Fonseca, R., Dueck, A., Chesi, M., Chesi, M. & Dueck, A.
9/1/15 → 8/31/20
Project: Research project
-
Specialized Program of Research Excellence in Myeloma
Fonseca, R., Bergsagel, L., Hideshima, T., Kufe, D. W., Anderson, K. C., Munshi, N. C., Kufe, D. W., Cozen, W., Munshi, N. C., Anderson, K. C., Weller, E., Bradner, J., Munshi, N. C. & C.Anderson, K.
9/1/03 → 8/31/18
Project: Research project
-
CHROMOSOMAL ABNORMALITIES IN MYELOMA AS DETECTED BY FISH
Fonseca, R. & Kinney, L.
4/1/00 → 7/31/14
Project: Research project
Research output
-
Chromosome 1q21 abnormalities in multiple myeloma
Schmidt, T. M., Fonseca, R. & Usmani, S. Z., Apr 2021, In: Blood cancer journal. 11, 4, 83.Research output: Contribution to journal › Review article › peer-review
-
Clinical correlates and prognostic impact of clonal hematopoiesis in multiple myeloma patients receiving post-autologous stem cell transplantation lenalidomide maintenance therapy
Wudhikarn, K., Padrnos, L., Lasho, T., LaPlant, B., Kumar, S., Dispenzieri, A., Lacy, M., Rajkumar, S. V., Gertz, M., Mangaonkar, A. A., Gonsalves, W., Ketterling, R., Shi, C. X., Fonseca, R., Stewart, A. K. & Patnaik, M. M., May 1 2021, In: American journal of hematology. 96, 5, p. E157-E162Research output: Contribution to journal › Letter › peer-review
Open Access -
Economic burden of disease progression among multiple myeloma patients who have received transplant and at least one line of therapy in the US
Fonseca, R., Hagiwara, M., Panjabi, S., Yucel, E., Buchanan, J. & Delea, T., Feb 2021, In: Blood cancer journal. 11, 2, 35.Research output: Contribution to journal › Article › peer-review
Open Access -
Treatment of AL Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement 2020 Update
Muchtar, E., Dispenzieri, A., Gertz, M. A., Kumar, S. K., Buadi, F. K., Leung, N., Lacy, M. Q., Dingli, D., Ailawadhi, S., Bergsagel, P. L., Fonseca, R., Hayman, S. R., Kapoor, P., Grogan, M., Abou Ezzeddine, O. F., Rosenthal, J. L., Mauermann, M., Siddiqui, M., Gonsalves, W. I., Kourelis, T. V. & 18 others, , Jun 2021, In: Mayo Clinic proceedings. 96, 6, p. 1546-1577 32 p.Research output: Contribution to journal › Review article › peer-review
-
Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group
Moreau, P., Kumar, S. K., San Miguel, J., Davies, F., Zamagni, E., Bahlis, N., Ludwig, H., Mikhael, J., Terpos, E., Schjesvold, F., Martin, T., Yong, K., Durie, B. G. M., Facon, T., Jurczyszyn, A., Sidana, S., Raje, N., van de Donk, N., Lonial, S., Cavo, M. & 50 others, , Mar 2021, In: The Lancet Oncology. 22, 3, p. e105-e118Research output: Contribution to journal › Review article › peer-review
2 Scopus citations